Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

1.6K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.6K
Adult Stem Cells01:33

Adult Stem Cells

27.7K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
27.7K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

2.7K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psmd13, a proteasome regulatory subunit identified in miR-29a regulation during neuronal differentiation.

PloS one·2026
Same author

Distinct Enterovirus Antigen Landscape in Children With Islet Autoimmunity.

Diabetes·2026
Same author

Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort.

Diabetologia·2025
Same author

Towards curing type 1 diabetes: Prospects and challenges of allogeneic or xenogeneic donor islet cell transplantation.

World journal of transplantation·2025
Same author

Potentially novel surrogate biomarker for diagnosing insulin resistance in type 2 diabetes.

World journal of diabetes·2025
Same author

Genetic variance in the murine defensin locus modulates glucose homeostasis.

The EMBO journal·2025

Related Experiment Video

Updated: Apr 25, 2026

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts
11:44

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Published on: September 26, 2010

23.7K

Pancreatic stem cells remain unresolved.

Fang-Xu Jiang1, Grant Morahan

  • 11 Islet Cell Development Program, Harry Perkins Institute of Medical Research, and Centre for Medical Research, The University of Western Australia , Perth, Australia .

Stem Cells and Development
|August 19, 2014
PubMed
Summary

Regenerating insulin-producing beta cells is key for diabetes treatment. This review explores pancreatic stem cells (PSCs) as a promising source for endogenous regeneration, overcoming limitations of current cell therapies.

More Related Videos

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas
09:31

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas

Published on: June 10, 2016

8.8K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts
11:44

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Published on: September 26, 2010

23.7K
In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas
09:31

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas

Published on: June 10, 2016

8.8K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Area of Science:

  • Endocrinology and Regenerative Medicine

Background:

  • Diabetes mellitus results from insufficient insulin-producing islet beta cells.
  • Current treatments like islet transplantation face limitations due to cell availability and differentiation challenges.
  • Embryonic stem cells and induced pluripotent stem cells show potential but struggle with functional differentiation.

Purpose of the Study:

  • To review the latest advancements in identifying and utilizing pancreatic stem cells (PSCs) for diabetes therapy.
  • To discuss the potential of PSCs as an endogenous source for regenerating insulin-secreting cells.
  • To explore strategies for overcoming challenges in PSC research and clinical application.

Main Methods:

  • Review of current scientific literature on pancreatic stem cells and diabetes regeneration.
  • Analysis of studies investigating pluripotent stem cells and their differentiation into beta cells.
  • Examination of research on endogenous pancreatic cell sources for regenerative therapy.

Main Results:

  • Pluripotent stem cells have limitations in generating functional beta cells for diabetes treatment.
  • Pancreatic stem cells (PSCs) offer a potential renewable source for endogenous beta cell regeneration.
  • Research into PSCs is crucial for developing alternative, sustainable diabetes therapies.

Conclusions:

  • Pancreatic stem cells (PSCs) represent a vital, albeit controversial, area of research for diabetes treatment.
  • Further development of PSC-based therapies could overcome current limitations in beta cell replacement.
  • Harnessing endogenous regeneration through PSCs is a key future direction for diabetes research.